EADV 2026
Understanding Chronic Spontaneous Urticaria: Mast Cell Pathways, New Approvals and the Therapeutic Pipeline
An expert overview of pathomechanism and the emerging therapeutic pipeline,
Saif Quadri
October 21, 2026
An expert overview of pathomechanism and the emerging therapeutic pipeline,
SETTING THE SCENE JAK1 inhibition in AD has been validated
SETTING THE SCENE Both JAK1 inhibitors and dupilumab produce impressive
SETTING THE SCENE Facial AD in children with skin of
SETTING THE SCENE The 2% crisaborole formulation is one of
A systematic review and meta-analysis presented at the 2026 ACOG
A large population-based study presented at the 2026 ACOG Scientific
A quality improvement initiative presented at the 2026 ACOG Scientific
Researchers presenting at the 2026 American College of Obstetricians and
Women managing gestational diabetes with a continuous glucose monitor were
New research presented today at the ACOG Annual Clinical and
A sweeping new study presented today at the ACOG Annual